Petra Pharma Competitors and Similar CompaniesClear all

Petra Pharma's competitors and similar companies include Scynexis, NGM Biopharmaceuticals, Azafaros and CStone Pharmaceuticals.

	Petra Pharma Petra Pharma is a drug development company focused on therapies for serious medical conditions such as cancer and metabolic diseases.	Scynexis Scynexis is engaged in drug discovery, development and manufacturing projects in various areas.	NGM Biopharmaceuticals NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.	Azafaros Azafaros is a medical drug development company intended to provide assistance for the treatment of rare metabolic disorders.	CStone Pharmaceuticals CStone Pharmaceuticals is a biopharmaceutical company devoted to the development of a new generation of innovative drugs.
Founding Date	Founding Date 2016	Founding Date 2000	Founding Date 2007	Founding Date 2018	Founding Date 2016
Type	Type Subsidiary	Type Public	Type Public	Type Private	Type Private
Tags	Tags Healthcare drug development healthtech therapy	Tags Healthcare biotech drug development pharma pharmacy women's health	Tags Healthcare biotech drug development pharma	Tags Healthcare drug development healthtech therapy	Tags Healthcare drug development healthtech pharma therapy
Locations	Locations New York, US HQ	Locations Jersey City, US HQ	Locations South San Francisco, US HQ	Locations Leiden, NL HQ Southport, AU Basel, CH	Locations Suzhou, CN HQ Beijing, CN Shanghai, CN
Employees	Employees 20	Employees 3636% decrease	Employees 18622% increase	Employees 215% decrease	Employees 1932% decrease
Valuation ($)	Valuation ($) N/A	Valuation ($) 53 m	Valuation ($) 128.5 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) $20.6m (FY, 2025)	Revenue (est.) $4.4m (FY, 2023)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income N/A	Net income ($8.6m) (FY, 2025)	Net income ($142.4m) (FY, 2023)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round N/A	Latest funding round N/A	Latest funding round $ 27.5m (over 6 years ago)	Latest funding round $ 260m (almost 8 years ago)
Total funding raised	Total funding raised $ 48m	Total funding raised $ 11.5m	Total funding raised N/A	Total funding raised $ 27.5m	Total funding raised $ 410m